Although we are not aware of any published clinical or xenograft data utilizing only RT and HDAC inhibitors in lung cancer models, some interesting observations were made during an in vitro study using NSCLC cell lines (34). This evidence concerns the gene HDAC9 and non-small cell lung carcinoma.